Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.
Condition:   Metastatic Breast Cancer Interventions:   Drug: Disulfiram;   Drug: Vinorelbin;   Drug: Cisplatin;   Drug: Copper Sponsor:   National Cancer Institute, Slovakia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 11, 2020 Category: Research Source Type: clinical trials

Determination of ClotPro Paediatric Reference Range Study
Conditions:   Clotting and Bleeding Disorders;   Child Development;   Infant Development;   Coagulopathy Intervention:   Diagnostic Test: thromboelastometry test (TEM test) Sponsor:   National Institute of Children's Diseases, Slovakia Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 9, 2019 Category: Research Source Type: clinical trials